At 6.7% CAGR, the South & Central America dPCR and qPCR Market is Projected to be Worth US$ 974.29 Million by 2030, Says Business Market Insights

According to Business Market Insights research, the South & Central America dPCR and qPCR market was valued at US$ 579.36 million in 2022 and is expected to reach US$ 974.29 million by 2030, registering a CAGR of 6.7% from 2022 to 2030. Development of droplet digital PCR and growing adoption of PCR methods in emerging countries are among the critical factors attributed to the South & Central America dPCR and qPCR market expansion.

Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, development of ddPCR would become a major trend in the South & Central America dPCR and qPCR market in the future.

On the contrary, high costs of PCR systems hampers the growth of South & Central America dPCR and qPCR market.

Based on treatment, the South & Central America dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held 69.4% share of the South & Central America dPCR and qPCR market in 2022, amassing US$ 401.85 million. It is projected to garner US$ 698.52 million by 2030 to expand at 7.2% CAGR during 2022-2030.

By product, the South & Central America dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 62.9% share of the South & Central America dPCR and qPCR market in 2022, amassing US$ 364.65 million. It is projected to garner US$ 643.11 million by 2030 to expand at 7.3% CAGR during 2022-2030.

By application, the South & Central America dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held 57.9% share of the South & Central America dPCR and qPCR market in 2022, amassing US$ 335.73 million. It is projected to garner US$ 629.50 million by 2030 to expand at 8.2% CAGR during 2022-2030. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the South & Central America dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held 57.9% share of the South & Central America dPCR and qPCR market in 2022, amassing US$ 335.73 million. It is projected to garner US$ 629.50 million by 2030 to expand at 8.2% CAGR during 2022-2030.

Based on country, the South & Central America dPCR and qPCR market is segmented into segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil held 61.5% share of South & Central America dPCR and qPCR market in 2022, amassing US$ 356.22 million. It is projected to garner US$ 631.56 million by 2030 to expand at 7.4% CAGR during 2022-2030.

Key players operating in the South & Central America dPCR and qPCR market are Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Standard BioTools Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc, among others.




Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com